
Artificial Intelligence in Healthcare Diagnosis Market Report 2026
Global Outlook – By Component (Software, Services, Hardware), By Diagnosis (Cardiology, Oncology, Pathology, Radiology, Chest And Lung, Neurology, Other Diagnoses), By Modality (MRI (Magnetic Resonance Imaging), CT (Computed Tomography), X-ray, Ultrasound), By Application (In Vivo Diagnostics, In Vitro Diagnostics), By End-User (Hospitals, Diagnostics Imaging Centers, Diagnostics Laboratories, Other End-Users) – Market Size, Trends, Strategies, and Forecast to 2035
Artificial Intelligence in Healthcare Diagnosis Market Overview
• Artificial Intelligence in Healthcare Diagnosis market size has reached to $33.03 billion in 2025 • Expected to grow to $226.56 billion in 2030 at a compound annual growth rate (CAGR) of 47.1% • Growth Driver: Navigating The Rise In Chronic Diseases With Ai-Driven Diagnosis • Market Trend: Industry Leaders Embraces Redefining Healthcare Diagnosis With AI Solutions • North America was the largest region in 2025.What Is Covered Under Artificial Intelligence in Healthcare Diagnosis Market?
Artificial intelligence (AI) in healthcare diagnosis refers to applying AI techniques, such as machine learning and deep learning algorithms, to diagnose medical conditions. It is employed to evaluate data, including clinical trials, medical records, and genetic information, that can aid medical practitioners in making a diagnosis much more quickly than any human could. The main types of components included in artificial intelligence in healthcare diagnosis are software, services, and hardware. Software refers to a collection of programs, data, and instructions that are designed to perform specific tasks on a computer or electronic device. These are used in various diagnoses, including cardiology, oncology, pathology, radiology, chest and lung, neurology, and others. The types of modalities are included, such as MRI (magnetic resonance imaging), CT (computed tomography), X-ray, and ultrasound, which are used for various applications, such as in vivo diagnostics and in vitro diagnostics. It is used by various end-users, including hospitals, diagnostic imaging centers, diagnostic laboratories, and others.
What Is The Artificial Intelligence in Healthcare Diagnosis Market Size and Share 2026?
The artificial intelligence in healthcare diagnosis market size has grown exponentially in recent years. It will grow from $33.03 billion in 2025 to $48.39 billion in 2026 at a compound annual growth rate (CAGR) of 46.5%. The growth in the historic period can be attributed to rising diagnostic workloads, shortage of medical specialists, growth of electronic health records, need for diagnostic accuracy, expansion of digital healthcare systems.What Is The Artificial Intelligence in Healthcare Diagnosis Market Growth Forecast?
The artificial intelligence in healthcare diagnosis market size is expected to see exponential growth in the next few years. It will grow to $226.56 billion in 2030 at a compound annual growth rate (CAGR) of 47.1%. The growth in the forecast period can be attributed to increasing adoption of AI diagnostics, growth of precision medicine, demand for faster diagnosis, integration of AI with hospital systems, regulatory approvals for AI tools. Major trends in the forecast period include ai-assisted clinical diagnosis, predictive diagnostic analytics, automated medical data interpretation, integrated diagnostic decision support, multi-modality diagnostic platforms.Global Artificial Intelligence in Healthcare Diagnosis Market Segmentation
1) By Component: Software, Services, Hardware 2) By Diagnosis: Cardiology, Oncology, Pathology, Radiology, Chest And Lung, Neurology, Other Diagnoses 3) By Modality: MRI (Magnetic Resonance Imaging), CT (Computed Tomography), X-ray, Ultrasound 4) By Application: In Vivo Diagnostics, In Vitro Diagnostics 5) By End-User: Hospitals, Diagnostics Imaging Centers, Diagnostics Laboratories, Other End-Users Subsegments: 1) By Software: Diagnostic Software, Imaging Analysis Software, Predictive Analytics Software 2) By Services: Consulting Services, Implementation Services, Maintenance And Support Services 3) By Hardware: Diagnostic Imaging Devices, AI-Powered Medical Devices, Data Storage And Processing HardwareWhat Is The Driver Of The Artificial Intelligence in Healthcare Diagnosis Market?
The rising incidence rate of chronic diseases is expected to propel the growth of artificial intelligence in the healthcare diagnosis market going forward. Chronic diseases are long-term health conditions that generally progress slowly over time and often persist intermittently. Artificial Intelligence (AI) in healthcare diagnosis has the potential to significantly impact the management and diagnosis of chronic diseases, as it can aid in cost savings and improved resource use. It can help medical practitioners make better decisions, spot patients in danger, and give more individualised care. For instance, in April 2025, according to the International Diabetes Federation (IDF), a Belgium-based non-profit organisation, 589 million people had diabetes in 2024, and by 2050, that number is expected to increase to 853 million. Therefore, the rising incidence rate of chronic diseases is driving the growth of artificial intelligence in the healthcare diagnosis market.Key Players In The Global Artificial Intelligence in Healthcare Diagnosis Market
Major companies operating in the artificial intelligence in healthcare diagnosis market are Johnson and Johnson Private Limited; Intel Corporation; International Business Machines Corporation; Medtronic; Nvidia Corporation; Siemens Healthcare GmbH; Koninklijke Philips N.V.; GE Healthcare; Agfa-Gevaert Group; Google Deep Mind; Babylon Health; HeartFlow Inc.; Corti HQ; Aidoc; Aidoc Medical Ltd.; Imagen Technologies; AliveCor Inc.; Digital Diagnostics Inc.; Enlitic Inc.; NovaSignal Corp.; Cleerly Inc.; Butterfly Network Inc.; IBM Watson Health; Arterys Inc.; Zebra Medical Vision Inc.; Vuno Inc.; Riverain Technologies; CloudMedX Inc.; Neural Analytics Inc.Global Artificial Intelligence in Healthcare Diagnosis Market Trends and Insights
Major companies operating in the artificial intelligence in the healthcare diagnosis market are concentrating their efforts on developing innovative solutions such as AI-powered disease detection. AI-powered disease detection refers to the application of artificial intelligence (AI) technologies to analyse medical data, such as images, patient records, and diagnostic tests, in order to identify and detect the presence of diseases or health conditions. For instance, in May 2023, Aegis Ventures LLC, a US-based next-generation venture studio and Northwell Holdings, a US-based medical technology company, announced the launch of ‘Optain’. Optain's AI utilises images of the eye taken with a simple, portable retinal camera. Its analyses can not only screen for eye-related conditions but also identify 140 diseases located throughout the body. The objective is to detect these diseases as early as possible when they are most treatable.What Are Latest Mergers And Acquisitions In The Artificial Intelligence in Healthcare Diagnosis Market?
In April 2025, HEALWELL AI, a Canada-based healthcare artificial intelligence company, acquired Orion Health Holdings Limited for approximately NZD 175 million (USD $104 million), with an additional earn-out of up to NZD 25 million (USD $103 million). Through this acquisition, HEALWELL artificial intelligence (AI) aims to enhance its AI-powered clinical decision-support capabilities by integrating Orion Health’s interoperability and data-management technologies across enterprise healthcare networks. Orion Health Holdings Limited is a New Zealand-based global healthcare intelligence platform that serves public-sector healthcare clients.Regional Insights
North America was the largest region in the artificial intelligence in healthcare diagnosis market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, SpainWhat Defines the Artificial Intelligence in Healthcare Diagnosis Market?
The artificial intelligence (AI) in healthcare diagnosis market consists of revenues earned by entities by providing medical imaging analysis, genetic analysis, clinical decision support, risk prediction and stratification. The market value includes the value of related goods sold by the service provider or included within the service offering. The artificial Intelligence (AI) in the healthcare diagnosis market also includes sales of surgical robots and visual tools which are used in providing AI in healthcare diagnosis services. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.What Key Data and Analysis Are Included in the Artificial Intelligence in Healthcare Diagnosis Market Report 2026?
The artificial intelligence in healthcare diagnosis market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence in healthcare diagnosis industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Artificial Intelligence in Healthcare Diagnosis Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $48.39 billion |
| Revenue Forecast In 2035 | $226.56 billion |
| Growth Rate | CAGR of 46.5% from 2026 to 2035 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 - 2035 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2035 |
| Segments Covered | Component, Diagnosis, Modality, Application, End-User |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, ... |
| Key Companies Profiled | Johnson and Johnson Private Limited; Intel Corporation; International Business Machines Corporation; Medtronic; Nvidia Corporation; Siemens Healthcare GmbH; Koninklijke Philips N.V.; GE Healthcare; Agfa-Gevaert Group; Google Deep Mind; Babylon Health; HeartFlow Inc.; Corti HQ; Aidoc; Aidoc Medical Ltd.; Imagen Technologies; AliveCor Inc.; Digital Diagnostics Inc.; Enlitic Inc.; NovaSignal Corp.; Cleerly Inc.; Butterfly Network Inc.; IBM Watson Health; Arterys Inc.; Zebra Medical Vision Inc.; Vuno Inc.; Riverain Technologies; CloudMedX Inc.; Neural Analytics Inc. |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
